Medical disclaimer: This article is for general information only. Smart rings are wellness screening tools, not medical devices, and they do not diagnose atrial fibrillation. Nothing here is medical advice. If you have a heart-rhythm concern or receive an irregular-rhythm alert, consult a qualified healthcare professional.
A smart ring detects AFib by using its optical sensor to time the gaps between heartbeats, then running an AI classifier that recognizes the chaotic, patternless irregularity atrial fibrillation produces. It never sees the heart's electrical signal the way an ECG does, yet Oura Ring 4 and Samsung Galaxy Ring both hold FDA clearance for irregular-rhythm notification. The clever part is how the AI reads a rhythm disorder from a light sensor never designed to measure electricity.
Why Is AFib Hard to Detect Without an ECG?
Atrial fibrillation is an electrical disorder. Normally the heart's sinoatrial node fires regular impulses that drive an evenly timed beat. In AFib the atria fire chaotically, so the heart beats at irregular intervals with no repeating pattern.
The gold standard for spotting this is the ECG, which uses skin electrodes to read the heart's electrical activity directly. A smart ring has no electrodes, only an optical PPG sensor measuring blood-volume changes in your finger. The AI's job is to pull enough from that indirect signal to flag the same irregularity an ECG shows directly.
What Does the Optical Signal Show During AFib?
The PPG sensor detects a pulse of blood with each heartbeat, and the gap between pulses, the inter-beat interval, tracks the timing of your heartbeats.
In normal rhythm those intervals are consistent, varying only slightly with breathing, which is what HRV measures. In AFib the intervals are chaotically irregular: some beats bunch together, others spread far apart. The AI does not need to reconstruct an ECG or see the P wave. It only needs to tell AFib-style irregularity apart from normal rhythm.
How Does the AI Classification Work?
The algorithm takes a sequence of inter-beat intervals and classifies the rhythm as normal or possibly AFib. The exact pipelines are proprietary, but the published approach behind FDA-cleared devices follows three stages.
1. Extract and clean the intervals. Peak-detection finds each heartbeat and records the gaps between them. Motion and poor contact create bad readings, so the pipeline discards low-quality data. This is why AFib detection runs mainly during rest and sleep, not exercise, when the signal is clean.
2. Measure rhythm regularity. From a clean interval sequence, the AI computes features that capture how irregular the rhythm is. A Poincaré plot, which graphs each interval against the next, is central: normal rhythm forms a tight cloud, while AFib scatters into a diffuse, structureless spray. Other measures, like sample entropy, capture how unpredictable the sequence is, since AFib has no repeating pattern.
3. Classify the rhythm. These features feed a classifier trained on labeled data from patients with confirmed AFib and confirmed normal rhythm. Approaches range from logistic regression to neural networks reading the interval sequence directly. On clean data, well-trained classifiers reach sensitivity of roughly 90 to 97 percent and specificity of 90 to 96 percent. The output is a probability, and the alert threshold is set conservatively to limit false alarms, which means some true episodes may not trigger a notification.
What Did FDA Clearance Require?
To clear AFib notification, Oura and Samsung submitted clinical data comparing their device against a reference ECG in people with and without confirmed AFib. Submissions typically had to show high sensitivity and specificity against that reference, in a sample large enough to be statistically meaningful, in a representative population.
Crucially, the cleared indication is a notification of irregular rhythm that may be consistent with AFib, not a diagnosis. The FDA reviewed both the performance and the labeling to ensure the device does not overstate what it does. Diagnosis still requires clinical confirmation.
What Can the AI Not Do?
Paroxysmal AFib. AFib that comes and goes may simply not be happening during the ring's clean monitoring window. One normal night does not rule it out.
Other arrhythmias. Some conditions, like frequent premature beats, can produce irregular intervals that mimic AFib to an optical sensor. Only a clinical ECG can tell these apart.
Movement. Detection needs clean data, so it runs during rest and sleep. An AFib episode during exercise would likely be missed.
Conclusion:
A smart ring detecting AFib is a genuine feat of AI signal processing: it reads a serious rhythm disorder from finger blood-flow timing alone, accurately enough to earn FDA clearance. But it is a screening tool, not a diagnosis. It can miss intermittent AFib, confuse other arrhythmias, and only works reliably at rest. Used correctly, as a passive early warning that prompts a doctor visit rather than a verdict, it is one of the most clinically valuable things a consumer wearable does today.
(FAQs):
Q1: Can a smart ring replace a Holter monitor for AFib?
A: No. A Holter records a continuous clinical-grade ECG of every rhythm event over 24 to 48 hours. A ring gives a screening signal that can prompt investigation but cannot produce a clinical ECG record. For known or strongly suspected AFib, a Holter or event monitor gives far more diagnostic information.
Q2: How does Apple Watch ECG compare to a ring's PPG for AFib?
A: Apple Watch uses a single-lead ECG that measures the heart's electrical signal directly. A ring infers rhythm from optical pulse timing instead. The ring monitors passively during sleep, while the watch ECG needs a deliberate 30-second recording. Both hold FDA clearance.
Q3: What should I do if my ring flags a possible AFib episode?
A: Contact your healthcare provider and mention the alert, without assuming a diagnosis. They will likely order an ECG or extended monitoring to confirm or rule it out. If you also feel palpitations, breathlessness or chest discomfort, seek prompt medical attention. Detected early, AFib is highly manageable.
.Technical details draw on FDA clearance documentation for Oura Ring 4 and Samsung Galaxy Ring, and peer-reviewed PPG-based arrhythmia research as of 2026. This article does not provide medical advice.